Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-Ageing Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Hormonal Therapy
  • 1.3.3 Antioxidants
  • 1.3.4 Enzymes
  • 1.3.5 Stem Cells
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-Ageing Drugs Market Share by Application (2019-2025)
  • 1.4.2 Skin
  • 1.4.3 Hair
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Ageing Drugs Market Size
  • 2.1.1 Global Anti-Ageing Drugs Revenue 2014-2025
  • 2.1.2 Global Anti-Ageing Drugs Sales 2014-2025
• 2.2 Anti-Ageing Drugs Growth Rate by Regions
  • 2.2.1 Global Anti-Ageing Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Anti-Ageing Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-Ageing Drugs Sales by Manufacturers
  • 3.1.1 Anti-Ageing Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-Ageing Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-Ageing Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-Ageing Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-Ageing Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-Ageing Drugs Price by Manufacturers
• 3.4 Key Manufacturers Anti-Ageing Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
• 3.6 Key Manufacturers Anti-Ageing Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Hormonal Therapy Sales and Revenue (2014-2019)
  • 4.1.2 Antioxidants Sales and Revenue (2014-2019)
  • 4.1.3 Enzymes Sales and Revenue (2014-2019)
  • 4.1.4 Stem Cells Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Anti-Ageing Drugs Sales Market Share by Type
• 4.3 Global Anti-Ageing Drugs Revenue Market Share by Type
• 4.4 Anti-Ageing Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-Ageing Drugs Sales by Application

6 United States

• 6.1 United States Anti-Ageing Drugs Breakdown Data by Company
• 6.2 United States Anti-Ageing Drugs Breakdown Data by Type
• 6.3 United States Anti-Ageing Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-Ageing Drugs Breakdown Data by Company
• 7.2 European Union Anti-Ageing Drugs Breakdown Data by Type
• 7.3 European Union Anti-Ageing Drugs Breakdown Data by Application

8 China

• 8.1 China Anti-Ageing Drugs Breakdown Data by Company
• 8.2 China Anti-Ageing Drugs Breakdown Data by Type
• 8.3 China Anti-Ageing Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-Ageing Drugs Breakdown Data by Company
• 9.2 Rest of World Anti-Ageing Drugs Breakdown Data by Type
• 9.3 Rest of World Anti-Ageing Drugs Breakdown Data by Application
• 9.4 Rest of World Anti-Ageing Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-Ageing Drugs Sales by Countries
  • 9.4.2 Rest of World Anti-Ageing Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Nu Skin
  • 10.1.1 Nu Skin Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-Ageing Drugs
  • 10.1.4 Anti-Ageing Drugs Product Introduction
  • 10.1.5 Nu Skin Recent Development
• 10.2 BIOTIME
  • 10.2.1 BIOTIME Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-Ageing Drugs
  • 10.2.4 Anti-Ageing Drugs Product Introduction
  • 10.2.5 BIOTIME Recent Development
• 10.3 Elysium Health
  • 10.3.1 Elysium Health Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-Ageing Drugs
  • 10.3.4 Anti-Ageing Drugs Product Introduction
  • 10.3.5 Elysium Health Recent Development
• 10.4 La Roche-Posay
  • 10.4.1 La Roche-Posay Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-Ageing Drugs
  • 10.4.4 Anti-Ageing Drugs Product Introduction
  • 10.4.5 La Roche-Posay Recent Development
• 10.5 DermaFix
  • 10.5.1 DermaFix Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-Ageing Drugs
  • 10.5.4 Anti-Ageing Drugs Product Introduction
  • 10.5.5 DermaFix Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-Ageing Drugs Sales Channels
  • 11.2.2 Anti-Ageing Drugs Distributors
• 11.3 Anti-Ageing Drugs Customers

12 Market Forecast

• 12.1 Global Anti-Ageing Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-Ageing Drugs Sales Forecast by Type
• 12.3 Global Anti-Ageing Drugs Sales Forecast by Application
• 12.4 Anti-Ageing Drugs Forecast by Regions
  • 12.4.1 Global Anti-Ageing Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-Ageing Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
In 2019, the market size of Anti-Ageing Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Ageing Drugs.

This report studies the global market size of Anti-Ageing Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Ageing Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
...

Market Segment by Product Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others

Market Segment by Application
Skin
Hair
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-Ageing Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Ageing Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-Ageing Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025